U.S. Wireless Telecom Stock News

NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Qfin Holdings (QFIN) Margin Compression Tests Bullish Earnings Narratives

Qfin Holdings (NasdaqGS:QFIN) has released its FY 2025 numbers with fourth quarter revenue of C¥4.1b and basic EPS of C¥7.92, setting the stage for investors to reassess how the earnings story lines up with expectations. Over the past six quarters, the company has seen quarterly revenue move between C¥4.1b and C¥5.2b, while basic EPS has ranged from C¥7.92 to C¥13.41, giving you a clear view of how the top line and per share profits have tracked through different trading periods. With...
OTCPK:FREV.S
OTCPK:FREV.SREITs

First Real Estate Investment Trust Of New Jersey (OTCPK:FREV.S) Steady FFO Base Challenges Bearish Narratives

First Real Estate Investment Trust of New Jersey (FREV.S) opened Q1 2026 with total revenue of US$7.5 million and basic EPS of US$0.13, giving investors a clean read on how the new fiscal year is starting. The company has seen quarterly revenue move in a tight band around US$7.2 million to US$7.5 million since early 2024, while basic EPS has ranged from about US$0.08 to US$0.15 over that stretch. This sets a clear baseline for how earnings power has tracked alongside a largely steady top...
NasdaqGS:VRNS
NasdaqGS:VRNSSoftware

Varonis Atlas Launch Puts AI Security And SaaS Story In Focus

Varonis Systems (NasdaqGS:VRNS) has launched Varonis Atlas, a comprehensive AI Security Platform for enterprises. Atlas is designed to manage the full AI lifecycle, including discovery, posture management, compliance, risk management, real-time guardrails, and monitoring. The platform targets AI agents, large language models, and shadow AI across corporate environments. Varonis Systems is known for data security and analytics, and Atlas extends that focus into AI security as companies roll...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax AI Security Focus Highlights Governance And Valuation Questions

Equifax (NYSE:EFX) released its 2025 Security Annual Report, outlining a major focus on AI-driven cybersecurity in response to rising digital threats. The company is urging shareholders to vote against a proposal that would lower the threshold for investors to call special meetings. Both developments center on risk management and corporate governance, key areas of interest for investors after past security incidents. Equifax operates as a global data, analytics, and technology company, with...
NasdaqGS:ASO
NasdaqGS:ASOSpecialty Retail

Academy Sports And Outdoors (ASO) Margin Compression Challenges Bullish Earnings Narratives

Academy Sports and Outdoors (ASO) has just wrapped up FY 2026 with fourth quarter revenue of US$1,718.5 million, basic EPS of US$2.02 and net income of US$133.7 million, setting a clear benchmark for how the business is currently earning its money. Over recent periods the company has seen quarterly revenue move from US$1,676.9 million in Q4 FY 2025 to US$1,718.5 million in Q4 FY 2026, while basic EPS shifted from US$1.93 to US$2.02 and trailing twelve month net income sat at US$376.8 million...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

GitLab (GTLB) Revenue Growth And Contained Losses Test Bullish Profitability Narratives

GitLab's FY 2026 results set the stage for a margins story GitLab (GTLB) closed FY 2026 with fourth quarter revenue of US$260.4 million and a basic EPS loss of US$0.02 per share, alongside trailing twelve month revenue of US$955.2 million and a TTM EPS loss of US$0.34. The company has seen quarterly revenue move from US$196.0 million in Q3 FY 2025 to US$260.4 million in Q4 FY 2026, while quarterly EPS has shifted from a profit of US$0.18 to a loss of US$0.02 over the same stretch, leaving...
NYSE:PRI
NYSE:PRIInsurance

Is Primerica (PRI) Pricing Reflect Its Franchise Model Strengths And Recent Share Performance

If you are wondering whether Primerica's current share price still offers value, the recent mix of returns gives you a useful starting point to question what the market is really pricing in. The stock last closed at US$248.46, with returns of a 1% decline over 7 days, a 1% decline over 30 days, a 4% decline year to date, while still showing gains of 60.3% over 3 years and 87.2% over 5 years. Recent news coverage has focused on Primerica's role as a US insurance provider and distributor of...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

Is Manhattan Associates (MANH) Still Attractive After Recent Share Price Weakness?

Wondering if Manhattan Associates at around US$138 per share still offers value, or if most of the opportunity has already been priced in. The stock is down about 3.6% over the past week, 1.6% over the past month, and 17.4% year to date, with a 20.8% decline over the last year and a 19.5% gain over five years. These moves can change how investors think about both risk and opportunity. Recent coverage has focused on Manhattan Associates as a key player in supply chain and warehouse management...
NYSE:CWK
NYSE:CWKReal Estate

Cushman And Wakefield Taps Victoria Lake To Shape APAC And EMEA Finance

Cushman & Wakefield (NYSE:CWK) has appointed Victoria Lake as Chief Financial Officer for its APAC & EMEA regions. Lake joins the company from Accenture, bringing experience in corporate development, M&A and strategic finance. The appointment reflects a focus on the company’s international business outside the US. Cushman & Wakefield, a global commercial real estate services firm, generates revenue from services such as leasing, property management, capital markets and advisory work...
NYSE:WSM
NYSE:WSMSpecialty Retail

Williams Sonoma (WSM) Margin Decline Questions Premium P E Narrative After FY 2026 Results

Williams-Sonoma (WSM) has wrapped up FY 2026 with fourth quarter revenue of US$2.4b and basic EPS of US$3.09, set against a trailing twelve month revenue base of US$7.8b and EPS of US$8.96. Over recent quarters the company has seen revenue move from US$2.5b in Q4 FY 2025 to US$2.4b in Q4 FY 2026, while quarterly EPS shifted from US$3.12 to US$3.09. This is prompting investors to focus on how modest growth expectations line up with a slightly lower trailing net margin and what that may...
NYSE:SLG
NYSE:SLGOffice REITs

SL Green Refocuses Portfolio As 7 Dey Sale Meets Leasing Momentum

SL Green Realty (NYSE:SLG) has agreed to sell the residential and retail components of 7 Dey Street. The company reports that One Madison Avenue is now fully leased. SL Green also highlights significant Manhattan leasing activity so far this year. For investors watching NYSE:SLG, these updates come at a time when the stock trades at $38.37 and has seen very different returns over various time frames, with a 1.5% gain over the past week alongside a 31.8% decline over the past year and a...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

Is It Time To Reconsider F5 (FFIV) After Its Recent Mixed Share Price Performance?

Wondering if F5 at around US$282.20 is offering good value or asking too much? This breakdown is designed to help you frame that question clearly before you make any moves. The stock has seen mixed recent returns, with a 2.5% decline over the last 7 days, a 3.0% gain over the past month, 10.0% year to date, and 4.4% over the last year. The 3 year and 5 year returns stand at 100.6% and 42.7% respectively. Recent coverage around F5 has focused on how investors are weighing long term...
NYSE:ADC
NYSE:ADCRetail REITs

How Agree Realty’s Higher Monthly Dividend and Institutional Demand Will Impact Agree Realty (ADC) Investors

Agree Realty Corporation recently declared a monthly cash dividend of US$0.262 per common share and US$0.08854 per Series A preferred depositary share, with the payouts scheduled in April 2026 to shareholders of record in March, marking an annualized increase in the common dividend. This dividend increase, alongside very large growth in institutional holdings and reaffirmed analyst confidence, highlights how income-focused investors view Agree Realty’s retail-focused portfolio as an...
NYSE:NAT
NYSE:NATOil and Gas

Nordic American Tankers Vessel Sale Puts Focus On Fleet And Valuation

Nordic American Tankers (NYSE:NAT) has agreed to sell a 2005 built vessel for around US$40 million. Management describes the transaction as aligned with the company’s current positioning and plans for future fleet growth. The deal affects fleet composition and adds flexibility around capital allocation going forward. The sale comes as Nordic American Tankers trades at a share price of US$5.42, with the stock up 3.4% over the past week and 19.4% over the past month. Returns of 60.8% year to...
NasdaqGS:BSVN
NasdaqGS:BSVNBanks

Bank7 (BSVN) High 45% Net Margin Softens Narrative Of Fully Stable Earnings

Bank7 (BSVN) FY 2025 earnings snapshot Bank7 (BSVN) has wrapped up FY 2025 with fourth quarter revenue of US$24.1 million and basic EPS of US$1.14, while trailing 12 month revenue came in at US$95.7 million and EPS at US$4.56. Over the past six quarters, revenue has ranged between US$22.6 million and US$24.9 million per quarter as EPS moved between US$1.10 and US$1.26. This gives you a clear line of sight on how the top line and per share profits have tracked into the latest print. With a net...
NYSE:GIS
NYSE:GISFood

General Mills (GIS) Margin Compression In Q3 2026 Reinforces Bearish Earnings Narratives

General Mills (GIS) has just posted its Q3 2026 numbers, with revenue at US$4.4b and basic EPS of US$0.57, set against a trailing twelve month EPS of US$4.07 on revenue of US$18.4b. Over recent quarters the company has seen revenue move from US$4.8b in Q2 2026 and US$4.5b in Q1 2026 to the latest US$4.4b print, while basic EPS shifted from US$0.77 and US$2.22 in those periods to US$0.57. This sets up a results season where investors are likely to focus squarely on how margins are holding up...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Brinsupri Launch Gives Insmed A New Respiratory Revenue Pillar

Insmed (NasdaqGS:INSM) has launched Brinsupri, also known as brensocatib, for non cystic fibrosis bronchiectasis. Brinsupri is the first approved therapy for this condition and has already generated significant initial sales. The successful launch marks a material commercial milestone for Insmed and adds a new revenue stream alongside its existing portfolio. Insmed focuses on treatments for serious and rare respiratory diseases, so the approval and rollout of Brinsupri fit directly into its...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

A Look At Capital Clean Energy Carriers (CCEC) Valuation After Pivot Toward Gas Assets And Long Term LNG Charters

Capital Clean Energy Carriers (CCEC) recently sold 12 container vessels, raised about US$472.2 million in net proceeds, and redirected that capital into gas transportation assets, including newbuilding LNG carriers on long-term charters. See our latest analysis for Capital Clean Energy Carriers. Despite the recent asset sales and LNG charter wins, the share price is around US$20.21 with a 30 day share price return of about an 11% decline. The 1 year total shareholder return of 5.67% and 3...
NasdaqGS:SCOR
NasdaqGS:SCORMedia

Comscore (SCOR) Q4 Profitability Surge Challenges Multi Year Loss Narrative

comScore FY 2025 earnings snapshot comScore (SCOR) just closed out FY 2025 with Q4 revenue of US$93.5 million and basic EPS of US$12.77, alongside full year trailing twelve month figures showing revenue of US$357.5 million and a net loss of US$101.8 million. Over recent quarters the company has seen revenue move in a narrow band between US$85.7 million and US$94.9 million per quarter. At the same time, basic EPS has swung from a loss of US$12.79 to a profit of US$12.77. This leaves investors...
NYSE:INFQ
NYSE:INFQTech

Infleqtion’s 100 Qubit UK System Puts Neutral Atom Thesis To Test

Infleqtion (NYSE:INFQ) has delivered the UK’s first operational 100-qubit quantum computer to the National Quantum Computing Centre. The system is based on Infleqtion’s Sqale platform and is the only operational 100-physical-qubit quantum computing system currently installed in a UK national facility. This deployment gives UK researchers and industry direct access to larger scale neutral atom hardware for benchmarking and application testing. For investors watching quantum hardware,...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Palomar Revenue Beat Renews Focus On Catastrophe Risk And Valuation

Palomar Holdings (NasdaqGS:PLMR) reported strong fourth quarter results, with revenue figures that were materially ahead of earlier analyst expectations. The quarter highlighted performance in the company’s catastrophe insurance focus, an area closely watched by investors given recent weather and loss events. This update reflects current operating momentum for Palomar’s specialty insurance franchise and has not been widely discussed in recent coverage. Palomar focuses on specialty and...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

A Look At Amneal Pharmaceuticals (AMRX) Valuation After Strong 2025 Results And 2026 Growth Guidance

Amneal Pharmaceuticals (AMRX) is back in focus after reporting 2025 results, with revenue of US$3.02b, operating income of US$421m, and lower net leverage of 3.5x, alongside 2026 guidance pointing to adjusted EBITDA and EPS growth. See our latest analysis for Amneal Pharmaceuticals. The recent pullback, including a 16.4% 1 month share price return decline to US$12.39, sits against a much stronger backdrop. The 1 year total shareholder return is 41.9%, and the 3 year total shareholder return...
NYSE:MCY
NYSE:MCYInsurance

Is It Too Late To Consider Mercury General (MCY) After Its Strong Multi‑Year Rally?

If you are wondering whether Mercury General at around US$87.85 is still offering value or if most of the opportunity has already played out, this overview helps you frame that question clearly. The stock has pulled back with a 0.8% decline over 7 days and a 6.0% decline over 30 days, following very strong returns of 56.5% over 1 year, 216.2% over 3 years and 71.8% over 5 years. Recent attention around the stock has focused on its longer term share price performance and how that compares...
NYSE:VLTO
NYSE:VLTOCommercial Services

A Look At Veralto (VLTO) Valuation After Recent Share Price Weakness

Event context and recent price performance Veralto (VLTO) has been on investors’ radar after recent share price weakness, with the stock down about 11% over the past 3 months and roughly 9% over the past year. See our latest analysis for Veralto. With the share price at $89.99 and a 90 day share price return of 10.7% and 1 year total shareholder return of 8.9%, recent weakness suggests momentum has been fading as investors reassess growth prospects and risk. If this kind of pullback has you...